Is a complete RVMD research report available?

No complete published report is available for Revolution Medicines, Inc. (RVMD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · USD

$181

-2.94 (-1.6%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first RVMD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	38.5B
Net income (ttm)	-1.4B
EPS (ttm)	-$7.12
Shares out	212.6M
Volume	2,299,333
Beta	1.38
Price target	$207	+14.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.4B
EPS (ttm): -$7.12
Market cap: 38.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All RVMD indicators

Market & fundamental data

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001628171
Company name	Revolution Medicines, Inc.
Country	United States
Country code	US
Cusip	76155X100
Employees	883
Employees Change	349%
Employees Change Percent	65.36
Enterprise value	$37B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-02-13
Isin	US76155X1000
Last refreshed	2026-07-30
Market cap	$38.5B
Market cap category	Large-Cap
Price	$181
Price currency	USD
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2836
Symbol	RVMD
Website	https://www.revmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.57%
EV Sales Forward	127.03x
FCF yield	-2.79%
P/B ratio	24.15x
PS Forward	132.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-1.1B
Net Income	$-1.4B
Net Income Growth Years	0%
Profit Per Employee	$-1.6M
ROA	-37.53
Roa5y	-21.66
ROCE	-70.61
ROE	-76.67
Roe5y	-39.1
ROIC	-41.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	386.09%
Cagr3y	91.6%
Cagr5y	43.64%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$2.3B
Cash	$1.9B
Current Assets	$2B
Current Liabilities	$289.6M
Debt	$437.3M
Debt Equity	$0.29
Equity	$1.5B
Interest Coverage	-38.07
Liabilities	$753.8M
Long Term Assets	$285.8M
Long Term Liabilities	$464.2M
Net Cash	$1.5B
Net Cash By Market Cap	$3.82
Net Cash Growth	-25.28%
Net Debt Equity	$-0.98
Tangible Book Value	$1.4B
Tangible Book Value Per Share	$7.14
WACC	11.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.8
Net Working Capital	$-213.2M
Quick ratio	6.59
Working Capital	$1.7B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.96%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	385.56%
200-day SMA	114
3Y total return	603.7%
50-day SMA	169.8
50-day SMA vs 200-day SMA	50over200
5Y total return	511.22%
All Time High	194.6
All Time High Change	-7.01%
All Time High Date	2026-07-27
All Time Low	14.08
All Time Low Change	1,184.94%
All Time Low Date	2022-05-12
ATR	7.15
Beta	1.38
Beta1y	2.72
Beta2y	1.51
Ch YTD	127.1
High	185
High52	194.6
High52 Date	2026-07-27
High52ch	-7.01%
Low	178.1
Low52	34
Low52 Date	2025-08-07
Low52ch	432.12%
Ma50ch	6.52%
Premarket Change Percent	0.47
Premarket Price	$185
Premarket Volume	656
Price vs 200-day SMA	58.66%
RSI	50.86
RSI Monthly	85.91
RSI Weekly	72.88
Sharpe ratio	2.6x
Sortino ratio	6.37
Total Return	-10.96%
Tr YTD	127.1
Tr1m	-0.64%
Tr1w	-1.15%
Tr3m	24.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	22
Analyst Count Top	19
Analyst Price Target Top	$196
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-2.01
Earnings Revenue Estimate	39,725,200x
Operating Income	$-1.4B
Price target	$207
Price Target Change	$14.42
Price Target Change Top	$8.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194,110,848%
Float Percent	91.3%
Shares Insiders	2.26%
Shares Institutions	87.88%
Shares Out	212,596,462
Shares Qo Q	0.73%
Shares Yo Y	10.96%
Short Float	7.21%
Short Ratio	4.41
Short Shares	6.59

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.3B
Adjusted OCF	-1,238,075,000
Average Volume	1,975,297.95x
Bv Per Share	7.49
CAPEX	$-14.3M
Ch1m	-0.64
Ch1w	-1.15
Ch1y	385.6
Ch3m	24.92
Ch3y	603.7
Ch5y	511.2
Ch6m	85.88
Change	-1.6%
Change From Open	-1.79
Close	183.9
Days Gap	0.19
Depreciation Amortization	8,437,000
Dollar Volume	415,995,326.4
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-1.4B
EBITDA	$-1.4B
EPS	$-7.12
F Score	1
FCF	$-1.1B
FCF EV Yield	-2.9x
FCF Per Share	$-5.04
Financing CF	859,394,000
Fiscal Year End	December
Founded	2,014
Goodwill	14,608,000
Investing CF	306,622,000
Ipr	964.2
Iprfo	541.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	130
Ma150ch	39.17%
Ma20	186.1
Ma20ch	-2.76%
Net CF	108,545,000
Next Earnings Date	2026-08-05
Open	184.2
Optionable	Yes
Position In Range	40.89
Post Close	180.9
Postmarket Change Percent	0.54
Postmarket Price	$182
Ppne	161,370,000
Pre Close	183.9
Price Date	2026-07-29
Ptbv Ratio	26.91
Relative Volume	1.16x
Share Based Comp	180,604,000
Tr6m	85.88%
Us State	California
Volume	2,299,333

Revolution Medicines, Inc. (RVMD)

Coverage state: Market snapshot only — no published research

Generate the first RVMD analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · RVMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All RVMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on RVMD

Frequently asked questions